Citizens, Inc. 2025 Annual Report (10-K) Summary
Business Context and Reporting Period
Company: Citizens, Inc. (NYSE: CIA)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: Citizens is an insurance holding company specializing in life insurance and endowment products. It operates through two primary segments: International Insurance (64% of premiums), selling U.S. dollar-denominated products to non-U.S. residents in over 80 countries, and Domestic Insurance (36% of premiums), focusing on final expense whole life products in 43 U.S. states. The company reported $1.8 billion in total assets and $5.4 billion in direct insurance in force as of year-end 2025.
Key Financial Metrics
| Metric (in thousands) | 2025 | 2024 |
|---|---|---|
| Total Revenues | $255,616 | $245,001 |
| Net Income | $14,591 | $14,912 |
| Income Before Tax | $17,470 | $14,980 |
| Diluted EPS (Class A) | $0.28 | $0.29 |
| Book Value Per Share | $4.67 | $4.19 (implied) |
| Adjusted Book Value Per Share | $6.43 | N/A |
| Total Assets | $1,754,760 | $1,685,325 |
| Net Cash Provided by Operating Activities | $17,986 | $31,918 |
| Debt | $0 | $0 |
Investment Portfolio: Total investments of $1.44 billion, with 89% in fixed maturity securities. The yield on average invested assets was 4.67% in 2025.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 4.3% to $255.6 million, driven by a 5.5% increase in direct premium revenues ($188.8 million) and improved investment income. This marks the second consecutive year of premium growth.
- Segment Performance:
- Domestic Insurance: Income before tax surged to $12.1 million from $1.9 million in 2024, driven by a 23% increase in first-year premiums and favorable mortality experience.
- International Insurance: Income before tax declined to $14.4 million from $23.5 million, primarily due to a record $76.8 million in matured endowment benefits.
- Expense Fluctuations: Total benefits and expenses increased $8.1 million. This was largely due to a $6.4 million increase in insurance benefits (matured endowments) and a $0.8 million increase in general expenses. However, 2024 expenses were inflated by a $3.5 million legal fee accrual related to a trade secret lawsuit, which did not recur in 2025.
- Investment Gains/Losses: Investment-related gains improved to $0.1 million in 2025 from a $2.6 million loss in 2024. The 2024 loss was driven by a BlackRock fund write-down, while 2025 saw positive fair value changes in other limited partnerships offsetting continued write-downs.
Guidance, Outlook, Risks, and Contingencies
- Strategic Outlook: Management continues to pursue a four-pronged strategy: growing first-year sales, improving policy retention, focusing on execution/technology, and maintaining financial discipline. The company issued $1.1 billion in new insurance in 2025, the second-highest amount in its history.
- Liquidity and Capital: The company maintains no debt and has a $20 million credit facility (unused). Liquidity is supported by operating cash flows and a highly liquid investment portfolio. However, the company faces potential liquidity strain from high matured endowment payouts and advance commission payments in the Domestic segment.
- Legal Contingency: The company is appealing a jury verdict from a 2024 trade secret lawsuit. The judgment requires Citizens to pay approximately $1.3 million in commissions and $3.5 million in legal fees to defendants. The company has filed an appeal bond and does not believe the judgment is valid, but the outcome remains uncertain.
- Key Risks:
- International Regulatory/Political Risk: Significant exposure to markets in Latin America (e.g., Venezuela, Colombia) and the Pacific Rim, where political instability, currency controls, and regulatory enforcement could disrupt sales.
- Interest Rate Risk: Rising rates have caused unrealized losses in the fixed maturity portfolio ($154.3 million gross unrealized losses), though no credit impairments were recorded.
- Reinsurance Concentration: Reliance on reinsurers (rated A- or higher) to manage risk; failure of a reinsurer could impact financial condition.
Investor Verification Checklist
- Appeal Status: Verify the current status and potential financial impact of the appeal regarding the trade secret lawsuit judgment ($4.8 million total exposure).
- Endowment Maturities: Confirm the trajectory of matured endowment payouts in 2026 and the company's ability to manage the associated cash outflows without forced asset sales.
- Domestic Growth Sustainability: Assess whether the 23% growth in domestic first-year premiums is sustainable given inflationary pressures on the lower-income demographic.
- International Regulatory Actions: Monitor for any new regulatory enforcement actions in key markets like Venezuela or Colombia that could restrict operations.
- Investment Portfolio Quality: Review the credit quality of the fixed maturity portfolio, specifically the $154.3 million in unrealized losses, to ensure no credit impairments are imminent.